Cargando…

Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer

The usage of beta blockers in breast cancer (BC) patients is implicated in the reduction in distant metastases, cancer recurrence, and cancer mortality. Studies suggest that the adrenergic pathway is directly involved in sympathetic-driven hematopoietic activation of pro-tumor microenvironmental pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardner, Kirby P., Cristofanilli, Massimo, Chumsri, Saranya, Lapidus, Rena, Tang, Cha-Mei, Raghavakaimal, Ashvathi, Adams, Daniel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266803/ https://www.ncbi.nlm.nih.gov/pubmed/35806301 http://dx.doi.org/10.3390/ijms23137299

Ejemplares similares

CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome
por: Raghavakaimal, Ashvathi, et al.
Publicado: (2022)

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
por: Adams, Daniel L., et al.
Publicado: (2016)

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer
por: Kasabwala, Dimpal M., et al.
Publicado: (2022)

Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes
por: Gardner, Kirby P., et al.
Publicado: (2021)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
por: Mu, Zhaomei, et al.
Publicado: (2016)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Circulating tumor cells in breast cancer: A tool whose time has come of age
por: Swaby, Ramona F, et al.
Publicado: (2011)

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
por: Cristofanilli, M
Publicado: (2005)

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
por: Krönig, Malte, et al.
Publicado: (2017)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
por: Giuliano, Mario, et al.
Publicado: (2014)

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
por: Mego, M, et al.
Publicado: (2009)

Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)

Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
por: Cristofanilli, Massimo
Publicado: (2012)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2022)

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer
por: Beck, Tim N., et al.
Publicado: (2019)

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
por: Giuliano, Mario, et al.
Publicado: (2011)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Beta-adrenergic receptors are expressed across diverse cancers
por: Rains, Steven L., et al.
Publicado: (2017)

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism
por: Abu-Khalaf, Maysa, et al.
Publicado: (2022)

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
por: Bingham, Catherine, et al.
Publicado: (2017)

Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer
por: Rossi, E, et al.
Publicado: (2012)

Circulating tumor cells in newly diagnosed inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2015)

Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors
por: Ravegnini, Gloria, et al.
Publicado: (2019)

Asymptomatic coronavirus disease 2019 mimicking metastatic breast cancer on positron emission tomography/computed tomography imaging
por: Pai, Tanmayi S., et al.
Publicado: (2021)

Monitoring PD-L1 Expression on Circulating Tumor–Associated Cells in Recurrent Metastatic Non–Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy
por: Moran, Jillian A., et al.
Publicado: (2022)

Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
por: Visal, Tanvi H., et al.
Publicado: (2022)

The Role of the Liver in the Adrenergic Regulation of Blood Flow from the Splanchnic to the Central Circulation
por: Rutlen, David L., et al.
Publicado: (1979)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Beta-adrenergic signaling, a novel target for cancer therapy?
por: Schuller, Hildegard M.
Publicado: (2010)

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
por: Mego, Michal, et al.
Publicado: (2012)

Increased Stromal Infiltrating Lymphocytes are Associated with Circulating Tumor Cells and Metastatic Relapse in Breast Cancer Patients After Neoadjuvant Chemotherapy
por: Liu, Jiawei, et al.
Publicado: (2019)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
por: Koch, Claudia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8tk3q6h635bm9nh5f0k40m5f7h